Wall Street analyst price targets, ratings consensus & upside potential · Updated Feb 28, 2026
Last 12 months price action with 12-month analyst target path
As of February 28, 2026, CareTrust REIT, Inc. (CTRE) has a Wall Street consensus price target of $42.11, based on estimates from 19 covering analysts. With the stock currently trading at $40.62, this represents a potential upside of +3.7%. The company has a market capitalization of $9.05B.
Analyst price targets range from a low of $39.00 to a high of $44.00, representing a 12% spread in expectations. The median target of $43.00 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Buy, with 14 analysts rating the stock as a Buy or Strong Buy,4 rating it Hold, and 1 rating it Sell or Strong Sell. This overwhelmingly bullish sentiment suggests analysts see significant catalysts for upside ahead.
From a valuation perspective, CTRE trades at a trailing P/E of 25.9x and forward P/E of 27.1x. The forward PEG ratio of 1.28 indicates reasonable valuation for growth. Analysts expect EPS to grow +21.7% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $38.81, with bear and bull scenarios of $8.07 and $27.44 respectively. Model confidence stands at 30/100, suggesting limited visibility into future performance.
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorSee our Bear / Base / Bull DCF models and intrinsic value estimates.
View ValuationSee how CTRE stacks up against sector leader Welltower Inc..
Start ComparisonThe consensus price target for CTRE is $42.11, close to the current price of $40.62 (3.7% implied move). Based on 19 analyst estimates, the stock appears fairly valued near current levels.
CTRE has a consensus rating of "Buy" based on 19 Wall Street analysts. The rating breakdown is predominantly bullish, with 14 Buy/Strong Buy ratings. The consensus 12-month price target of $42.11 implies 3.7% upside from current levels.
CTRE trades at a forward P/E of 27.1053x, representing a moderate valuation. With analysts targeting $42.11 (3.7% implied move), the stock appears close to fair value.
The most bullish Wall Street analyst has a price target of $44 for CTRE, while the most conservative target is $39. The consensus of $42.11 represents the median expectation. Our quantitative valuation model projects a bull case target of $27 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
CTRE is well covered by analysts, with 19 analysts providing price targets and ratings. Of these, 1 have Strong Buy ratings, 13 have Buy ratings, 4 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month CTRE stock forecast based on 19 Wall Street analysts shows a consensus price target of $42.11, with estimates ranging from $39 (bear case) to $44 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $39, with bear/bull scenarios of $8/$27.
Our quantitative valuation model calculates CTRE's fair value at $39 (base case), with a bear case of $8 and bull case of $27. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 30/100.
CTRE trades at a forward P/E ratio of 27.1x based on next-twelve-months earnings estimates compared to a trailing P/E of 25.9x. The higher forward P/E suggests near-term earnings pressure. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
CTRE appears fairly valued according to analysts, with a "Buy" rating and minimal upside to the $42.11 target. Consider your investment thesis and risk tolerance. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
CTRE analyst price targets range from $39 to $44, a 12% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $42.11 consensus represents the middle ground. Our model's $8-$27 range provides an independent fundamental perspective.